Clinical Trial Update: Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating the role of Sirtuin-1 and advanced glycation end-products in postmenopausal women with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: InCor Heart Institute | Conditions: Coronary Artery Disease Progression | Phase 3 | Status: UNKNOWN